Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:CNBS NYSEARCA:CRTC NYSEARCA:IDNA NYSEARCA:TRFK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCNBSAmplify Seymour Cannabis ETF$33.31+3.2%$19.89$13.96▼$57.93$121.25M1.6235,476 shs11,211 shsCRTCXtrackers US National Critical Technologies ETF$35.15+0.3%$34.45$25.78▼$35.49$124.78M0.9420,161 shs4,836 shsIDNAiShares Genomics Immunology and Healthcare ETF$22.37+1.1%$21.46$17.26▼$25.80$115.21M0.930,191 shs97,768 shsTRFKPacer Data and Digital Revolution ETF$61.28+0.6%$60.25$37.46▼$63.71$94.37M-1.3418,787 shs43,281 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCNBSAmplify Seymour Cannabis ETF+5.28%+8.46%+69.41%+97.13%-95.05%CRTCXtrackers US National Critical Technologies ETF-0.40%-0.34%-0.37%+8.96%+13.29%IDNAiShares Genomics Immunology and Healthcare ETF-3.66%-2.90%-0.23%+9.55%-11.48%TRFKPacer Data and Digital Revolution ETF-0.62%-1.73%-2.04%+17.13%+34.57%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCNBSAmplify Seymour Cannabis ETFN/AN/AN/AN/AN/AN/AN/AN/ACRTCXtrackers US National Critical Technologies ETFN/AN/AN/AN/AN/AN/AN/AN/AIDNAiShares Genomics Immunology and Healthcare ETFN/AN/AN/AN/AN/AN/AN/AN/ATRFKPacer Data and Digital Revolution ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCNBSAmplify Seymour Cannabis ETF 2.61Moderate Buy$33.31N/ACRTCXtrackers US National Critical Technologies ETF 2.82Moderate Buy$35.15N/AIDNAiShares Genomics Immunology and Healthcare ETF 2.68Moderate Buy$22.37N/ATRFKPacer Data and Digital Revolution ETF 2.76Moderate Buy$61.28N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCNBSAmplify Seymour Cannabis ETFN/AN/AN/AN/AN/AN/ACRTCXtrackers US National Critical Technologies ETFN/AN/AN/AN/AN/AN/AIDNAiShares Genomics Immunology and Healthcare ETFN/AN/AN/AN/AN/AN/ATRFKPacer Data and Digital Revolution ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCNBSAmplify Seymour Cannabis ETFN/AN/A17.73∞N/AN/AN/AN/AN/ACRTCXtrackers US National Critical Technologies ETFN/AN/A26.36∞N/AN/AN/AN/AN/AIDNAiShares Genomics Immunology and Healthcare ETFN/AN/A14.76∞N/AN/AN/AN/AN/ATRFKPacer Data and Digital Revolution ETFN/AN/A41.50∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCNBSAmplify Seymour Cannabis ETF$10.7132.15%N/AN/AN/ACRTCXtrackers US National Critical Technologies ETF$0.361.02%N/AN/AN/AIDNAiShares Genomics Immunology and Healthcare ETF$0.261.16%N/AN/AN/ATRFKPacer Data and Digital Revolution ETF$0.020.03%N/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCNBSAmplify Seymour Cannabis ETFN/ACRTCXtrackers US National Critical Technologies ETFN/AIDNAiShares Genomics Immunology and Healthcare ETFN/ATRFKPacer Data and Digital Revolution ETFN/AInsider OwnershipCompanyInsider OwnershipCNBSAmplify Seymour Cannabis ETFN/ACRTCXtrackers US National Critical Technologies ETFN/AIDNAiShares Genomics Immunology and Healthcare ETFN/ATRFKPacer Data and Digital Revolution ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCNBSAmplify Seymour Cannabis ETFN/A3.64 millionN/ANot OptionableCRTCXtrackers US National Critical Technologies ETFN/A3.55 millionN/AN/AIDNAiShares Genomics Immunology and Healthcare ETFN/A5.15 millionN/ANot OptionableTRFKPacer Data and Digital Revolution ETFN/A1.54 millionN/ANot OptionableTRFK, IDNA, CRTC, and CNBS HeadlinesRecent News About These CompaniesPacer ETFs Cuts Fees on Four Thematic Funds to Boost AccessibilityAugust 7, 2025 | msn.comPacer ETFs Announces Fee Reduction on Four FundsJuly 31, 2025 | finance.yahoo.comDisruptive Theme of the Week: Top ETF Themes Through Q3 2024October 3, 2024 | etftrends.comEBest ETFs Can Be Real Cash Cows In This Stock MarketJuly 5, 2024 | investors.comHere's Why These Tech ETFs Are Worth Buying NowMay 3, 2024 | zacks.comETFs in Focus Post Intel's Q1 Earnings Beat, Dismal OutlookApril 26, 2024 | zacks.comThematic ETF Plays on the Growing Digital EconomyApril 4, 2024 | etftrends.comETop-Ranked ETFs That Outperformed the Market in Q1April 2, 2024 | zacks.com5 Technology ETFs Outperforming XLK This YearMarch 7, 2024 | zacks.comMore Rally Awaits ETFs as Nvidia Hovers Around $2Tn Market Cap?March 1, 2024 | zacks.comNvidia ETFs to Tap for More Growth Post Blowout Q4 EarningsFebruary 22, 2024 | zacks.com7 Factors to Watch in Nvidia's Upcoming Earnings: ETFs in FocusFebruary 21, 2024 | zacks.comNvidia Likely to Beat on Q4 Earnings: 5 ETFs to TapFebruary 20, 2024 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTRFK, IDNA, CRTC, and CNBS Company DescriptionsAmplify Seymour Cannabis ETF NYSEARCA:CNBS$33.31 +1.02 (+3.16%) Closing price 04:10 PM EasternExtended Trading$33.42 +0.10 (+0.32%) As of 05:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Amplify Growth Opportunities ETF (CNBS) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed portfolio of global stocks related to cannabis and hemp. The fund also invests in derivatives with similar characteristics. CNBS was launched on Jul 23, 2019 and is managed by Amplify.Xtrackers US National Critical Technologies ETF NYSEARCA:CRTC$35.15 +0.12 (+0.34%) Closing price 04:10 PM EasternExtended Trading$35.10 -0.05 (-0.16%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Xtrackers US National Critical Technologies ETF (CRTC) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is passively managed to hold stocks from developed market countries associated with sectors determined vital to maintaining US national security. A committee selects the stocks based on a proprietary rating system and weights holdings based on market-cap. CRTC was launched on Nov 16, 2023 and is issued by Xtrackers.iShares Genomics Immunology and Healthcare ETF NYSEARCA:IDNA$22.37 +0.24 (+1.08%) Closing price 04:10 PM EasternExtended Trading$22.38 +0.02 (+0.07%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.Pacer Data and Digital Revolution ETF NYSEARCA:TRFK$61.28 +0.36 (+0.59%) Closing price 04:10 PM EasternExtended Trading$61.28 -0.01 (-0.01%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Pacer Data and Digital Revolution ETF (TRFK) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks market cap-weighted index of global companies involved in the use, manipulation, transmission, and storage of data, as well as the ancillary services that enable these processes. TRFK was launched on Jun 8, 2022 and is managed by Pacer. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Buffett’s Wisdom Could Spell Trouble for Palantir Shorts Tesla Just Had Its Best Day in 2 Months—Here’s What It Means Reynolds Consumer Products Stock Price: Insiders Signal a Bottom Ubiquiti's 30% Jump: Why This Was a Turnaround, Not Just a Trend Petrobras: Why Traders Are Betting Big on a Shareholder Payout Southern Company: From Nuclear Risk to AI Reward BJ’s Wholesale Club Pulls Back to Trend: It’s Time for an Entry Why Sprouts Farmers Market is Buying $1 Billion of Its Own Stock Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access